Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupal Mehta

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Translational Stroke Research|June 19, 2012
Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhageJ Marc Simard, Cigdem Tosun, Svetlana Ivanova, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 26, 2015
Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort StudyRupal Mehta, Gui Shuang Ying, Samuel Houston, et al.
American Journal of Preventive Medicine|May 25, 2019
Association of Fitness With Racial Differences in Chronic Kidney DiseaseAmanda E Paluch, Lindsay R Pool, Tamara Isakova, et al.
Stroke|October 12, 2013
Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhageCigdem Tosun, David B Kurland, Rupal Mehta, et al.
Bone|July 11, 2018
Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of LatinosRupal Mehta, Xuan Cai, Alexander Hodakowski, et al.
Journal of Cardiac Failure|October 9, 2020
Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection FractionJasleen Ghuman, Xuan Cai, Ravi B Patel, et al.
Kidney International|November 1, 2019
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney diseaseConnor Francis, Guillaume Courbon, Claire Gerber, et al.
Kidney International Reports|January 18, 2018
A Patient With CKD Develops Cholestatic Liver Injury During a Clinical TrialEmma D A Wagener, Nao Souma, Alexander Hodakowski, et al.
Hypertension (Dallas, Tex. : 1979)|May 2, 2018
FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA StudyEhimare Akhabue, Samantha Montag, Jared P Reis, et al.
Circulation. Cardiovascular Imaging|November 9, 2020
Fibroblast Growth Factor 23 and Long-Term Cardiac Function: The Multi-Ethnic Study of AtherosclerosisRavi B Patel, Hongyan Ning, Ian H de Boer, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Translational Stroke Research|June 19, 2012
Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhageJ Marc Simard, Cigdem Tosun, Svetlana Ivanova, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 26, 2015
Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort StudyRupal Mehta, Gui Shuang Ying, Samuel Houston, et al.
American Journal of Preventive Medicine|May 25, 2019
Association of Fitness With Racial Differences in Chronic Kidney DiseaseAmanda E Paluch, Lindsay R Pool, Tamara Isakova, et al.
Stroke|October 12, 2013
Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhageCigdem Tosun, David B Kurland, Rupal Mehta, et al.
Bone|July 11, 2018
Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of LatinosRupal Mehta, Xuan Cai, Alexander Hodakowski, et al.
Journal of Cardiac Failure|October 9, 2020
Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection FractionJasleen Ghuman, Xuan Cai, Ravi B Patel, et al.
Kidney International|November 1, 2019
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney diseaseConnor Francis, Guillaume Courbon, Claire Gerber, et al.
Kidney International Reports|January 18, 2018
A Patient With CKD Develops Cholestatic Liver Injury During a Clinical TrialEmma D A Wagener, Nao Souma, Alexander Hodakowski, et al.
Hypertension (Dallas, Tex. : 1979)|May 2, 2018
FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA StudyEhimare Akhabue, Samantha Montag, Jared P Reis, et al.
Circulation. Cardiovascular Imaging|November 9, 2020
Fibroblast Growth Factor 23 and Long-Term Cardiac Function: The Multi-Ethnic Study of AtherosclerosisRavi B Patel, Hongyan Ning, Ian H de Boer, et al.
Pageof 7